Medscape19h
Post-COVID Cough Linked to Neurological Dysfunction
Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...
Yahoo Finance13d
Trevi Therapeutics to Participate in Upcoming February Investor Conferences
Refractory chronic cough affects approximately 2-3 million adults in the U.S. and is caused by cough reflex hypersensitivity in both the central and peripheral nerves. It is highly disruptive and ...
Sacramento Bee9d
Exxel Pharma’s Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Refractory chronic cough represents a significant unmet ... to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today provided an overview of its EX937 ...
Yahoo Finance9d
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Refractory chronic cough represents a significant unmet ... to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today provided an overview of its EX937 ...